Log in to save to my catalogue

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03229516v1

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

About this item

Full title

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2021-09, Vol.35 (9), p.2672-2683

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Anti-PD-1 monoclonal antibodies yield high response rates in patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but most patients will eventually progress. Allogeneic hematopoietic cell transplantation (alloHCT) after PD-1 blockade may be associated with increased toxicity, raising challenging questions about the role, timing, and op...

Alternative Titles

Full title

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03229516v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03229516v1

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-021-01193-6

How to access this item